Linde Past Earnings Performance
Past criteria checks 4/6
Linde has been growing earnings at an average annual rate of 20.6%, while the Chemicals industry saw earnings declining at 3.8% annually. Revenues have been growing at an average rate of 4.9% per year. Linde's return on equity is 16.1%, and it has net margins of 19.3%.
Key information
20.6%
Earnings growth rate
22.8%
EPS growth rate
| Chemicals Industry Growth | 4.3% |
| Revenue growth rate | 4.9% |
| Return on equity | 16.1% |
| Net Margin | 19.3% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Linde makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 33,025 | 6,383 | 3,172 | 150 |
| 30 Jun 24 | 32,824 | 6,398 | 3,167 | 149 |
| 31 Mar 24 | 32,761 | 6,310 | 3,164 | 148 |
| 31 Dec 23 | 32,854 | 6,199 | 3,131 | 146 |
| 30 Sep 23 | 32,451 | 5,984 | 3,044 | 143 |
| 30 Jun 23 | 33,093 | 5,692 | 2,988 | 142 |
| 31 Mar 23 | 33,346 | 4,489 | 2,909 | 144 |
| 31 Dec 22 | 33,364 | 4,147 | 2,870 | 143 |
| 30 Sep 22 | 33,763 | 3,843 | 2,902 | 145 |
| 30 Jun 22 | 32,634 | 3,548 | 2,933 | 146 |
| 31 Mar 22 | 31,761 | 4,016 | 2,997 | 143 |
| 31 Dec 21 | 30,793 | 3,821 | 2,997 | 143 |
| 30 Sep 21 | 29,767 | 3,566 | 3,015 | 143 |
| 30 Jun 21 | 28,954 | 3,287 | 2,996 | 143 |
| 31 Mar 21 | 27,747 | 2,905 | 2,938 | 143 |
| 31 Dec 20 | 27,243 | 2,497 | 3,016 | 152 |
| 30 Sep 20 | 27,051 | 2,235 | 3,079 | 163 |
| 30 Jun 20 | 27,196 | 2,264 | 3,202 | 171 |
| 31 Mar 20 | 28,023 | 2,319 | 3,347 | 182 |
| 31 Dec 19 | 28,228 | 2,183 | 3,425 | 184 |
| 30 Sep 19 | 26,949 | 4,546 | 3,310 | 177 |
| 30 Jun 19 | 22,957 | 4,279 | 2,758 | 156 |
| 31 Mar 19 | 18,797 | 4,246 | 2,207 | 135 |
| 31 Dec 18 | 14,836 | 4,273 | 1,625 | 113 |
| 30 Sep 18 | 11,988 | 1,436 | 1,236 | 95 |
| 30 Jun 18 | 11,902 | 1,394 | 1,242 | 95 |
| 31 Mar 18 | 11,692 | 1,320 | 1,240 | 94 |
| 31 Dec 17 | 11,358 | 1,247 | 1,203 | 93 |
| 30 Sep 17 | 11,128 | 1,620 | 1,160 | 92 |
| 30 Jun 17 | 10,922 | 1,540 | 1,145 | 91 |
| 31 Mar 17 | 10,753 | 1,533 | 1,146 | 92 |
| 31 Dec 16 | 10,534 | 1,500 | 1,154 | 92 |
| 30 Sep 16 | 10,485 | 1,516 | 1,148 | 92 |
| 30 Jun 16 | 10,455 | 1,578 | 1,138 | 93 |
| 31 Mar 16 | 10,528 | 1,487 | 1,127 | 92 |
| 31 Dec 15 | 10,776 | 1,547 | 1,152 | 93 |
| 30 Sep 15 | 11,171 | 1,427 | 1,197 | 94 |
| 30 Jun 15 | 11,629 | 1,503 | 1,243 | 96 |
| 31 Mar 15 | 12,004 | 1,662 | 1,281 | 97 |
| 31 Dec 14 | 12,273 | 1,694 | 1,308 | 96 |
| 30 Sep 14 | 12,293 | 1,866 | 1,320 | 98 |
| 30 Jun 14 | 12,162 | 1,834 | 1,329 | 97 |
| 31 Mar 14 | 12,063 | 1,812 | 1,338 | 97 |
| 31 Dec 13 | 11,925 | 1,755 | 1,349 | 98 |
Quality Earnings: 0M2B has high quality earnings.
Growing Profit Margin: 0M2B's current net profit margins (19.3%) are higher than last year (18.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 0M2B's earnings have grown significantly by 20.6% per year over the past 5 years.
Accelerating Growth: 0M2B's earnings growth over the past year (6.7%) is below its 5-year average (20.6% per year).
Earnings vs Industry: 0M2B earnings growth over the past year (6.7%) exceeded the Chemicals industry -36.8%.
Return on Equity
High ROE: 0M2B's Return on Equity (16.1%) is considered low.